Bruce E. Sands — Endo Lab

article 2022

P209 Etrasimod improves quality of life in adults with moderate-to-severe ulcerative colitis

·doi:10.1136/gutjnl-2022-bsg.263

Introduction Active ulcerative colitis (UC) can significantly impact quality of life (QOL). Etrasimod (ETR) is a once-daily, oral, selective sphingosine 1–phosphate receptor 1, 4, and 5 modulator that demonstrated efficacy in inducing respo…

article 2021

S714 Etrasimod Improves Quality of Life in Adults With Moderate-to-Severe Ulcerative Colitis: Results From the Phase 2 OASIS Trial and Open-Label Extension

·doi:10.14309/01.ajg.0000776388.09359.02

Introduction: Active ulcerative colitis (UC) can significantly impact quality of life. Etrasimod (APD334) is an oral, selective sphingosine 1-phosphate receptor 1, 4, and 5 modulator that demonstrated efficacy in inducing response and remis…

article 2019

A Longitudinal Study of Sexual Function in Women With Newly Diagnosed Inflammatory Bowel Disease

·doi:10.1093/ibd/izy397

BACKGROUND: The literature provides conflicting data on sexual function in women with inflammatory bowel disease (IBD). We aim to describe sexual function at baseline and over time in a prospective inception cohort of adult women with IBD. …

article 2014

Menstrual Cycle Changes in Women with Inflammatory Bowel Disease

Inflammatory bowel diseases ·doi:10.1097/01.mib.0000441347.94451.cf

BACKGROUND: The effect of the inflammatory bowel diseases (IBD) on menstrual function is largely unknown. The aims of this study were to determine whether changes in menstrual function occur in the year before IBD diagnosis or in the initia…